Oncodaily

What are Zyn nicotine pouches and are they safe?

A tumour-derived organoid biobank maps cancer gene dependencies

Do Altered Immune Cells Drive Skin Cancer in Immunosuppressed Patients?

Ask An Expert: What You Need to Know About Lung Cancer Testing

Popular weight-loss drugs may help protect against a deadly disease, doctor says

Breast cancer checks missing most women under 50 who are at risk, says study

Study finds NHS breast cancer guidelines miss 95% of high‑risk women under 50, sparking calls for review.

Why more young adults are being diagnosed with colon cancer: Oncologist Dr Ravi K Gupta shares risk factors and symptoms

Toward a test of medical AI superintelligence

Medical and technology outlets are defining new frameworks to evaluate artificial superintelligence as it approaches clinical trial integration.

A Beaver County man is part of a clinical trial for a brain implant that collapses the time usually needed between surgery and radiation - Pittsburgh Post-Gazette

A new brain implant device is gaining attention for its ability to reduce the delay between surgery and radiation treatment for brain metastases.

Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients

A first-in-human clinical trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.

Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

New antibody drug stops aggressive prostate cancer from spreading

8 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Kids with deadliest brain cancers survive years after breakthrough cell therapy

6 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses

10 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Modular in vivo antibody–ADC click to reverse drug resistance in tumours

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Cancer rates are expected to nearly double in the next 24 years

A breakthrough in pancreatic cancer has experts excited

7 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61

The oncology community mourns the death of Maura Gillison, a doctor who transformed the treatment of mouth and throat cancers.

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector

Sanofi's Sarclisa becomes the first cancer drug approved by the FDA for delivery via an on-body injector for multiple myeloma.

Which ‘AI scientist’ suits your lab? A guide for the perplexed

5 news sources are covering this Technology story right now — Newsylist is tracking how fast it spreads.

Pancreatic cancer breakthrough has big implications for early detection effort - San Diego Union-Tribune

Experimental cancer treatment Daraxonrasib is gaining momentum as regulators fast-track review and clinical data suggests potential advancements in patient care.

Tobacco Companies Are Cashing In on Zyn’s Unstoppable Popularity

Tobacco companies are racing to capitalize on the surging popularity of Zyn and other smoke-free alternatives.

Revolution Medicines shares promising data around KRAS drug combination

Revolution Medicines has released promising Phase 1/2 clinical data for a KRAS drug combination targeting metastatic pancreatic cancer.

Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells

Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.

GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related Cancers

Rise in cancer in younger adults may be explained by faster 'biological aging,' early study hints

New blood test detects 90% of aggressive prostate cancer cases, beating current screenings

A new blood test, Stockholm3, is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.

What went right this week: the good news that matters

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.

Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS

Thousands of men with prostate cancer can now access high-powered radiotherapy via the NHS to treat early-stage disease more efficiently.

BIO 2026: How a gut feeling transformed cancer treatment forever

Why men die younger than women

Medical experts and news outlets are examining the biological and systemic factors contributing to the longevity gap between men and women.

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks

Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing

As cancer death rates plunge, clear disparities remain, new report says

Seattle scientists seek answers as colorectal cancer trends younger

Scientists and health experts are investigating a global rise in early-onset colorectal cancer among young adults, with new data emerging from the US and Germany.